EQRx, a company committed to developing and delivering important new medicines at lower prices, announced…
Arboretum_JDFebruary 22, 2021
CStone Pharmaceuticals recently announced an agreement to out-license ex-Greater China rights for two key late-stage…
Arboretum_JDOctober 28, 2020
Unlike the typical Fierce 15, EQRx isn’t yet looking for major innovation in the R&D…
Arboretum_JDSeptember 30, 2020
EQRx announced today that it is launching to create novel, patent-protected medicines at prices that…
Arboretum_JDJanuary 13, 2020
